WASHINGTON, June 26 /PRNewswire/ -- Many people see nanotechnology as a
futurist dream. Tomorrow's nano world promises pollution-free energy,
potent cancer and Alzheimer's treatments, and faster, smaller, cheaper
Few appreciate that nanotechnology is quickly moving out of
laboratories and into factories, stores, and homes. Lux Research reports
that more than $32 billion in products incorporating nanotechnology sold
last year. These include about 300 nanotechnology consumer products, and an
estimated 600 nanotechnology raw materials, intermediate components, and
industrial equipment items used by manufacturers.
What are the challenges of moving nanotechnology from laboratory to
store shelves? How do you use nanotechnology to add value to products, and
to shift competitive dynamics? Do you brand or not brand nanotechnology
products, and how do you address consumer perceptions? What does
responsible development of nanotechnology mean to a company?
A program to address these and other questions will be held on
Thursday, June 29th at 12:30 p.m. in the 6th floor board room of the
Woodrow Wilson International Center for Scholars.
The featured guest is Dr. Barry Park, chief operating officer of
Oxonica. Oxonica is one of Europe's leading nanomaterials firms taking
nano-enabled products from laboratory to market.
The company was spun out of Oxford University in Great Britain in 1999.
Its commercialized products include Envirox Fuel Borne Catalyst (used in
diesel engines to reduce fuel consumption and particulate emissions) and
Optisol UV Absorber (a photostable UV absorber that provides enhanced and
longer lasting protection against UVA in suncare and anti-aging products).
In 2005, Boots Group plc -- Britain's foremost pharmacy chain --
incorporated Optisol in their new Soltan Facial Sun Defense Cream, now sold
widely in stores throughout the United Kingdom.
Dr. Park formerly worked for Raychem Ltd. He is co-author of 20
scientific papers and is an inventor whose work has led to over 120 patents
This program is part of the Wilson Center's Project on Emerging
Nanotechnologies' "Perspectives" series aimed at stimulating an informed
dialogue on the development, commercialization, and oversight of
***Webcast LIVE at http://www.wilsoncenter.org/nano***
What: Taking Nanotechnology to Market: One Company's Strategy
Who: Barry Park, Ph.D., Chief Operating Officer, Oxonica
Andrew Maynard, Ph.D., Chief Scientist, Project on Emerging
When: Thursday, June 29, 2006, 12:30 - 1:30 p.m. (Lunch available
starting at 12 noon.)
Where: Woodrow Wilson International Center for Scholars, 6th Floor Board
Room. Ronald Reagan Building and International Trade Center, 1300
Pennsylvania Avenue, NW.
The Project on Emerging Nanotechnologies was launched in 2005 by the
Woodrow Wilson Center and The Pew Charitable Trusts. It is dedicated to
helping businesses, governments, and the public anticipate and manage the
possible health and environmental implications of nanotechnology.
Media planning to cover the event should contact Sharon McCarter at
(202) 691-4016 or at email@example.com.
SOURCE Woodrow Wilson International Center for Scholars